These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8754434)

  • 1. Women's responses to Depo-Provera.
    Freda MC; Abruzzo-Fogarassy M; Adams NV; Davini D; DeVore N; Merkatz IR
    MCN Am J Matern Child Nurs; 1996; 21(4):183-6. PubMed ID: 8754434
    [No Abstract]   [Full Text] [Related]  

  • 2. Medroxyprogesterone acetate [Depo Provera] injections. Development of striae.
    Gupta M
    Br J Fam Plann; 2000 Apr; 26(2):104-5. PubMed ID: 10773604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
    Hu E; Ikeako LC; Obiora-Okafor NC
    Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable contraception.
    Mishell DR
    J Reprod Med; 2002 Sep; 47(9 Suppl):777-9. PubMed ID: 12380405
    [No Abstract]   [Full Text] [Related]  

  • 6. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
    Potter LS; Dalberth BT; Cañamar R; Betz M
    Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous depo-medroxyprogesterone acetate.
    Cameron S
    J Fam Plann Reprod Health Care; 2013 Apr; 39(2):75-7. PubMed ID: 23493590
    [No Abstract]   [Full Text] [Related]  

  • 8. Contraceptive efficacy and safety of DMPA-SC.
    Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM
    Contraception; 2004 Oct; 70(4):269-75. PubMed ID: 15451329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute necrotic skin reaction to intramuscular Depo-Provera.
    Clark SM; Lanigan SW
    Br J Dermatol; 2000 Dec; 143(6):1356-7. PubMed ID: 11122072
    [No Abstract]   [Full Text] [Related]  

  • 11. Counseling teens and young women on Depo-Provera.
    Tonelli M; Nicoletti A
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):297-8. PubMed ID: 16171737
    [No Abstract]   [Full Text] [Related]  

  • 12. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
    Polis CB; Nakigozi GF; Nakawooya H; Mondo G; Makumbi F; Gray RH;
    Contraception; 2014 May; 89(5):385-95. PubMed ID: 24332432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beliefs about Depo-Provera among three groups of contraceptors.
    Cushman LF; Kalmuss D; Davidson AR; Heartwell S; Rulin M
    Adv Contracept; 1996 Mar; 12(1):43-52. PubMed ID: 8739515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A process model of Depo-Provera use in Canadian women.
    Hampton M; McWatters B
    Health Care Women Int; 2003 Mar; 24(3):193-208. PubMed ID: 12746011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
    Smit J; McFadyen L; Zuma K; Preston-Whyte E
    Soc Sci Med; 2002 Nov; 55(9):1511-22. PubMed ID: 12297238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia.
    Sobande AA; Al-Bar HM; Archibong EI; Sadek AA
    Saudi Med J; 2000 Apr; 21(4):348-51. PubMed ID: 11533816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception.
    Cameron ST; Glasier A; Johnstone A
    Contraception; 2012 May; 85(5):458-64. PubMed ID: 22079602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case for concern?
    Gartland A
    Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms and Depo-Provera.
    Westhoff C; Truman C; Kalmuss D; Cushman L; Davidson A; Rulin M; Heartwell S
    Contraception; 1998 Apr; 57(4):237-40. PubMed ID: 9649914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent clinical issues related to the use of depot medroxyprogesterone acetate (Depo-Provera).
    Cromer BA
    Curr Opin Obstet Gynecol; 1999 Oct; 11(5):467-71. PubMed ID: 10526923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.